Actinogen Medical (ACW) 2017年年度报告「ASX」.pdf

1、 ACTINOGEN MEDICAL LIMITED ABN 14 086 778 476 ANNUAL FINANCIAL STATEMENTS YEAR ENDED 30 JUNE 2017 ACTINOGEN MEDICAL LIMITED C O N T E N T S P A G E Contents Page Corporate Directory 1 Chairmans Address 2 Corporate Governance Statement 4 Directors Report 12 Auditors Independence Declaration 42 Statem

2、ent of Comprehensive Income 43 Statement of Financial Position 45 Statement of Cash Flows 46 Statement of Changes in Equity 47 Notes to the Financial Statements 48 Directors Declaration 75 Independent Auditors Report 76 Shareholder Information 81 ACTINOGEN MEDICAL LIMITED C O R P O R A T E D I R E C

3、 T O R Y 1 Board of DirectorsAuditorsNon-Executive Chairman Dr Geoffrey BrookeErnst&YoungManaging Director Dr Bill KetelbeyErnst&Young BuildingNon-Executive Director Dr Jason Loveridge11 Mounts Bay RoadPerth WA 6000Company SecretaryCompany Secretary-Peter WebseLawyersK&L GatesPrincipal Place of Busi

4、ness/Registered OfficeLevel 25 South TowerLevel 9,Suite 1,68 Pitt Street525 Collins StreetSydney NSW 2000Melbourne VIC 3000Contact DetailsGTP LegalTelephone:02 8964 740168 Aberdeen S.auNorthbridge WA 6003ABN 14 086 778 476BankersShare RegisterNational Australia BankLink Market Services1232 Hay Stree

5、tLevel 12West Perth WA 6005680 George StreetSydney NSW 2000Actinogen Medical Limited shares are listed on the Australia Stock Exchange(ASX).ASX Code:ACW ACTINOGEN MEDICAL LIMITED C H A I R M A N S A D D R E S S 2 Actinogen Medical Limited 2017 Shareholders Annual Report Message from the Chairman Dea

6、r Shareholder,On behalf of Actinogen Medical,I am pleased to present the 2017 annual report to our shareholders.Before discussing the past year,it is timely to reflect on Actinogen Medicals history.Its been just over 2.5 years since Actinogen Medical was founded,when the Company acquired the rights